Viemed Healthcare (Viemed Healthcare) EBIT : $15.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Viemed Healthcare EBIT?

Viemed Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $2.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $15.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Viemed Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 was 5.77%. Viemed Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 11.64%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Viemed Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.46%.

Viemed Healthcare EBIT Historical Data

The historical data trend for Viemed Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viemed Healthcare EBIT Chart

Viemed Healthcare Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

9.11

26.87

12.82

9.19

14.82

Viemed Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															1.91	3.02	4.48	5.33	2.27

Competitive Comparison of Viemed Healthcare's EBIT

For the Medical Devices subindustry, Viemed Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viemed Healthcare's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Viemed Healthcare's EV-to-EBIT falls into.

Viemed Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.1 Mil.

Viemed Healthcare (NAS:VMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Viemed Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	9.668 * ( 1 - 24.42% )	/	( (126.608	+	126.888)	/ 2 )
=	7.3070744	/	126.748
=	5.77 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	154.895	-	22.044	-	( 12.839	-	max(0, 32.124	-	38.367	+	12.839	))
=	126.608

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	154.875	-	20.678	-	( 7.309	-	max(0, 30.117	-	38.618	+	7.309	))
=	126.888

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Viemed Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	9.084	/	( ( (76.852 + max(-4.59, 0))	+	(76.541 + max(2.685, 0)) )	/	2 )
=	9.084	/	( ( 76.852	+	79.226 )	/	2 )
=	9.084	/	78.039
=	11.64 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(18.451	+	4.628	+	2.449)	-	(22.044	+	6.207	+	1.867)
=	-4.59

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(24.477	+	4.349	+	2.483)	-	(20.678	+	6.092	+	1.854)
=	2.685

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Viemed Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	15.097	/	276.297
	=	5.46 %

Viemed Healthcare EBIT Related Terms

Thank you for viewing the detailed overview of Viemed Healthcare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Viemed Healthcare (Viemed Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viemed Healthcare Inc (NAS:VMD) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

VIJ:Germany

Address

625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508

Website

https://www.viemed.com

Viemed Healthcare Inc is a provider of equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services.

Executives

Jeremy Trahan	officer: Chief Legal Officer	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Timothy Smokoff	director	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Nitin Kaushal	director	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Randy E. Dobbs	director	C/O VIEMED HEALTHCARE, INC, 625 E. KALISTE SALOOM RD, LAFAYETTE LA 70508
Bruce D Greenstein	director	901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
William Todd Zehnder	director, officer: Chief Operating Officer	400 E. KALISTE SALOOM ROAD, SUITE 6000, LAFAYETTE LA 70508
Casey Hoyt	director, officer: Chief Executive Officer	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Michael Moore	officer: President	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Trae Fitzgerald	officer: Chief Financial Officer	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
William Frazier	director, officer: Chief Medical Officer	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Jerome Cambre	officer: Vice President of Sales	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Sabrina Heltz	director	625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508
Ewell Patrick Eagan	officer: General Counsel	625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508